RE:RE:RE:NumbersVincenzovega wrote: Smokey, I listen to the video again and he is referring $1.00 per test in production costs, Play it again and you will see what I mean.
He does meantion before that, they will go from sell the device from $30 to $10
Let me know if im right or not... start playing the video at 12:42
SH: Rob, pivoting to the investment side of the business, what can you tell our investor audience regarding the current valuation of your stock and why you think its a smart buy right now? RF: Well, listen, I, you know, I'm not going to tell you to buy or sell. But I can say thisif you do the math here, if we can get this test sold for $30, let's say, and eventually scale that down to say $10 per test. And I can get my costs down to say $2.50 all in costs. You know, there's some very good margin in there, especially initially. But right now the cost is a little higher because the swab is the most expensive piece. Believe it or not, the rest of this stuff I showed you, the cartridge and the strip, we're talking pennies here. It doesn't cost a lot, but the, the swab does cost more. But we're hopeful that the swab price will come down. So let's say you make a dollar, a test, you know, and our aim is to do a million tests a month.If we can get to that, and we make a dollar per test, you can do the math. It's significant. The demand that we have from the distributors, the workplaces and the governmental buyers that have approached us, far exceeds one-million tests per month. And if we can get to 25 million tests per month, eventually again, you can do the math there, even on a dollar per test, heck of a margin there. So we're pretty excited about it. I think it's going to, in terms of valuation currently, the market wants to see what get through the R&D and then they want to know that you can produce it, scale it. And then I think, you know, you could really see a pretty exciting situation there with the stock down the road, in the very near term.